AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Two physicians in a busy hallway

Physician burnout is down. Here’s what’s working—and what isn’t.

| 11 Min Read
Paper airplane in the shadow of a rocket

Why the future favors physician entrepreneurs

| 6 Min Read
Older adult speaks with physician

What age-friendly care means for older adults

| 8 Min Read
Doctor applies bandage to patient's arm following an immunization

What doctors want patients to know about flu vaccines

| 12 Min Read